FDA Center for Drug Evaluation & Research Issues Warning Letter to Guangzhou Jiugong Research & Development Biotechnology
November 04, 2026
November 04, 2026
WASHINGTON, Nov. 4 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Guangzhou Jiugong Research And Development Biotechnology Co., Ltd. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Yun Ma, Product Manager, Guangzhou Jiugong Research And Development Biotechnology Co., Ltd., No. 3 Yiheng Road, Nanling Gongye Districtqinghu Ma Tian Street Jiahe Street, Baiyun Qu Guangz . . .
* * *
Recipient: Mr. Yun Ma, Product Manager, Guangzhou Jiugong Research And Development Biotechnology Co., Ltd., No. 3 Yiheng Road, Nanling Gongye Districtqinghu Ma Tian Street Jiahe Street, Baiyun Qu Guangz . . .